National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

aziridinylbenzoquinone RH1
A water-soluble, synthetic aziridinylbenzoquinone with potential antineoplastic activity. Bioactivation of aziridinylbenzoquinone RH1 occurs through the two-electron reduction of the quinone to the hydroquinone by the two-electron quinone reductase DT-diaphorase (DTD). The resultant hydroquinone selectively alkylates and cross-links DNA at the 5'-GNC-3' sequence, inihibiting DNA replication, inducing apoptosis, and inhibiting tumor cell proliferation. DTD is over-expressed in many tumors relative to normal tissue, including lung, colon, breast and liver tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:RH1
Chemical structure name:2,5-diaziridinyl-3-hydroxymethyl-6-methyl-1,4-benzoquinone



Previous:azacitidine, azapicyl, azaserine, azathioprine sodium, AZD0530
Next:Azixa, AZP, B7-DC cross-linking antibody rHIgM12B7, baclofen, baclofen/amitriptyline/ketamine gel

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov